OnDose is a simple blood test that helps oncologists to optimize infusional
5-Fluorouracil (5-FU) therapy.
OnDose provides the data for pharmacokinetically (PK)-guided dose adjustments of infusional 5-FU to help optimize dosing for patients with colorectal cancer (CRC).
Chemotherapy Foundation Symposium: Innovative Caner Therapy for Tomorrow
Watch a webcast by Dr. Kaplan discussing the importance of OnDose.
Personalized 5-Fluorouracil Dose Management: A Rational Approach to Improving Therapeutic Outcomes
Myriad, the Myriad logo, OnDose, and the OnDose logo are either trademarks or registered trademarks of Myriad Genetic Laboratories, Inc., in the United States and other jurisdictions.
© 2011 Myriad Genetic Laboratories, Inc.